Skip to main content
. 2018 Mar 21;15(5):7631–7638. doi: 10.3892/ol.2018.8309

Figure 3.

Figure 3.

In vivo analysis of the effects of CD74-knockdown cells. (A) Volume of tumors derived from CD74-knockdown cells was significantly decreased compared with those derived from control cells in vivo. (B) The average weight of the tumors was significantly decreased in in the CD74 shRNA group. (C) Untreated HT-1376 xenograft tumors exhibited strong CD74 signals by immunochemistry. (D) CD74 in the wild-type J82 tumor was indicated using immunostaining. *P<0.05 and **P<0.01 vs. Control shRNA. Magnification, ×100.